New Product Briefs: Hearing Device; Volcano’s iFR Modality; St. Jude Pain Device
This article was originally published in The Gray Sheet
Executive Summary
FDA approved Cochlear Ltd.’s Nucleus Hybrid L24 cochlear implant system, the first implantable device for adults with severe or profound sensorineural hearing loss. Volcano’s instant wave-Free Ratio (iFR) intravascular imaging modality is cleared based on ADVISE II results. More product news.